Coronavirus Disease Clinical Trial
Official title:
A Randomized, Double-blind, Multi-center Study to Evaluate the Efficacy and Safety of Ethyl Lauroyl Arginate Hydrochloride (LAEH) Formulation Versus a Matching Placebo Formulation
The Covixyl-V LAEH Nasal Spray's safety and efficay is clinically tested for use in subjects with COVID-19 infection. A randomized, double-blind, multi-center study is conducted to evaluate the efficacy and safety of ethyl lauroyl arginate hydrochloride (LAEH) formulation versus a matching placebo formulation administered as a nasal spray to reduce viral load from nasal area of subjects with coronavirus disease 2019 (COVID-19).
The primary endpoint for this study was the comparison of change in viral load in RT-PCR Test. Proportion of COVID-19 infection-free subjects between the two treatment arms was followed. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT04464460 -
A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults
|
Phase 1 | |
| Completed |
NCT04488588 -
Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt
|
||
| Recruiting |
NCT05922865 -
The Effect of Smart Sensor Combined With APP for Individualized Precise Exercise Training in Long Covid-19
|
N/A | |
| Recruiting |
NCT04479293 -
Post COVID-19 Functional Status in Egypt
|
||
| Withdrawn |
NCT05112874 -
ImmuneSense™ COVID-19 Cross-Reactivity Study
|
||
| Completed |
NCT04999111 -
A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2
|
Phase 2 | |
| Terminated |
NCT04369989 -
Observational Study of COVID-19 Treatment Efficacy
|